Clinica Ortopedica e Traumatologica 2, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
U.O. Ortopedia e Traumatologia, Ospedale Umberto I, Enna, Italy.
Am J Sports Med. 2024 Nov;52(13):3198-3205. doi: 10.1177/03635465241283052. Epub 2024 Oct 18.
Arthroscopic meniscectomy is one of the most performed surgical procedures in orthopaedics. Different approaches have been proposed to improve patient recovery but with unsatisfactory results. Platelet-rich plasma (PRP) augmentation has been proposed as a strategy to improve the recovery after meniscectomy.
To investigate the clinical benefits of an intra-articular PRP injection after meniscectomy, in terms of faster and better patient recovery.
Randomized controlled trial; Level of evidence, 1.
Ninety patients were randomized into a treatment group, with arthroscopic partial meniscectomy immediately followed by a 5-mL injection of autologous conditioned plasma, and a control group with partial meniscectomy alone. Patients were evaluated at baseline and at 15, 30, 60, and 180 days of follow-up with the visual analog scale (VAS) score for pain (primary outcome), as well as with International Knee Documentation Committee subjective score, Knee injury and Osteoarthritis Outcome Score subscales, Tegner score, and EuroQol-Visual Analog Scale score. Objective evaluation was performed analyzing knee range of motion and circumference and the International Knee Documentation Committee objective score. Complications, patient judgment, and satisfaction were documented as well.
No major complications and an overall significant improvement in the clinical scores were observed in both groups. Overall, the comparative analysis did not demonstrate significant between-group differences in absolute values or improvements of both subjective and objective scores, as well as activity level. The improvement in terms of VAS pain score for the treatment group was significant already at 15 days (from 4.3 ± 2.5 to 2.5 ± 2.5; = .014), while in the control group it became significant at 30 days (from 3.7 ± 2.3 to 2.0 ± 2.4; = .004). No significant differences were observed between the 2 groups in terms of judgment of treatment results and satisfaction.
A single postoperative injection of PRP was not able to significantly improve patient recovery after arthroscopic partial meniscectomy. PRP augmentation did not provide overall benefits at a short-term follow-up (6 months) in terms of pain relief, function, objective parameters, and return-to-sport activities.
NCT02872753 (ClinicalTrials.gov identifier).
关节镜下半月板切除术是矫形外科中最常进行的手术之一。已经提出了不同的方法来改善患者的恢复情况,但结果并不令人满意。富血小板血浆(PRP)的添加被提议作为改善半月板切除术后恢复的一种策略。
探讨关节镜下半月板切除术后关节内注射 PRP 对加速和改善患者恢复的临床益处。
随机对照试验;证据水平,1 级。
90 名患者随机分为治疗组(关节镜下部分半月板切除术,立即注射 5mL 自体条件血浆)和对照组(单纯部分半月板切除术)。患者在基线和 15、30、60 和 180 天的随访时使用视觉模拟评分(VAS)评估疼痛(主要结果),以及国际膝关节文献委员会主观评分、膝关节损伤和骨关节炎结果评分子量表、Tegner 评分和 EuroQol-视觉模拟评分。客观评估分析膝关节活动度和周长以及国际膝关节文献委员会客观评分。还记录了并发症、患者判断和满意度。
两组均未发生重大并发症,临床评分均显著改善。总体而言,对比分析并未显示两组在主观和客观评分以及活动水平的绝对值或改善方面存在显著差异。治疗组的 VAS 疼痛评分在 15 天时(从 4.3 ± 2.5 降至 2.5 ± 2.5; =.014)即有显著改善,而对照组在 30 天时(从 3.7 ± 2.3 降至 2.0 ± 2.4; =.004)才变得显著。两组在治疗效果和满意度的判断方面无显著差异。
关节镜下半月板部分切除术后单次注射 PRP 不能显著改善患者的恢复。在短期(6 个月)随访中,PRP 增强在缓解疼痛、功能、客观参数和重返运动活动方面没有提供整体益处。
NCT02872753(ClinicalTrials.gov 标识符)。